MigraSpray Advertisement in MMR ``Mass Market Retailer'' Trade Journal

Business Wire, May 8, 2001

Business Editors

LA JOLLA, Calif.--(BUSINESS WIRE)--May 8, 2001

NatureWell, Inc., formerly La Jolla Diagnostics, Inc., (OTC BB:NAWL), announced today that its first two full page advertisement for MigraSpray(TM) will appear in the May 14, 2001, issue of MMR, Mass Market Retailer.

MMR is a leading trade publication reaching Supermarket, Drug and Mass Merchandising/Wholesale chain executives. MMR's latest BPA, Bureau of Public Accounting, stated that 97% of its circulation is through direct personal request reaching the most powerful audiences in all of retailing -- over 27,000 headquarter executives and buyers.

NatureWell, Inc. is a company engaged in the development and marketing of unique, proprietary healthcare products including MigraSpray(TM). NatureWell signed an agreement with Mitchell Health Technologies, Inc. in November of last year for the marketing of MigraSpray(TM) and other products. Mitchell Health currently markets health and medical products to approximately 48,000 drug stores, food stores, and mass channels of distribution across the United States. In addition, through its subsidiary DiagnosTech Inc., NatureWell has licensed Meridian Diagnostics, Inc. (Nasdaq:VIVO) for worldwide marketing and distribution of a unique proprietary test for active tuberculosis.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties.